[PLX] QoQ Quarter Result on 30-Sep-2017 [#Q3]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
08-Nov-2017
Financial Year
2017
Quarter
30-Sep-2017 [#Q3]
Profit Trend
QoQ- -2,641.56%
YoY- -56.89%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
Revenue 2,006 4,553 2,469 7,526 6,358 2,889 2,081 -2.42%
PBT -11,294 -9,400 -15,141 -11,437 450 -59,148 -2,624 165.30%
Tax 75 132 916 8 3,045 2,087 -189 -
NP -11,294 -9,400 -15,141 -11,437 450 -59,148 -2,624 165.30%
Tax Rate - - - - -676.67% - - -
Total Cost 13,300 13,953 17,610 18,963 5,908 62,037 4,705 100.30%
Ratio Analysis
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
NP Margin -563.01 -206.46 -613.24 -151.97 7.08 -2,047.35 -126.09 171.90%
Per Share
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
EPS -0.77 -0.65 -1.08 -0.86 0.04 -4.75 -0.21 138.34%
EPS Diluted -0.77 -0.65 -1.04 -0.86 -0.60 -4.75 -0.21 138.34%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.